On naming H2 haplotypes: Functional significance of MHC class Ib alleles

被引:27
作者
Lindahl, KF [1 ]
机构
[1] UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA
关键词
D O I
10.1007/s002510050242
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
George D. Snell began defining and naming the H2 haplotypes many years ago by histogenetic typing. Since then, a few haplotypes have been given an additional letter, such as bc for strain 129, to show that they are minor variants from the prototype (b). But by and large, differences in nonclassical class I antigens have been known (only?) to those in the field without being acknowledged by a separate haplotype symbol. Thus, strains BALB/c and NZB/B1NJ are both considered H2(d) and strains C3H/HeJ and B10.BR are both called H2(k), although each pair differs in the TL and Qa1 antigens. In parallel with the interest in nonclassical class I antigens, the need for an appropriate haplotype nomenclature is growing. The haplotypes that require splitting are b, d, k, q, and s; the symbol be should be retained and used, and, for the other haplotypes, the suffix 2 denotes a QaI(a) haplotype with highly TL-positive thymocytes.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 139 条
[1]   IDENTIFICATION OF A TAP-DEPENDENT LEADER PEPTIDE RECOGNIZED BY ALLOREACTIVE T-CELLS SPECIFIC FOR A CLASS IB ANTIGEN [J].
ALDRICH, CJ ;
DECLOUX, A ;
WOODS, AS ;
COTTER, RJ ;
SOLOSKI, MJ ;
FORMAN, J .
CELL, 1994, 79 (04) :649-658
[2]  
ALLEN SL, 1955, CANCER RES, V15, P315
[3]  
AMADOU C, 1996, THESIS U P SABATIER
[4]   H-39, A HISTOCOMPATIBILITY LOCUS CLOSELY LINKED TO T-T COMPLEX [J].
ARTZT, K ;
HAMBURGER, L ;
FLAHERTY, L .
IMMUNOGENETICS, 1977, 5 (05) :477-480
[5]   RECOGNITION OF A LIPID ANTIGEN BY CD1-RESTRICTED ALPHA-BETA(+) T-CELLS [J].
BEEKMAN, EM ;
PORCELLI, SA ;
MORITA, CT ;
BEHAR, SM ;
FURLONG, ST ;
BRENNER, MB .
NATURE, 1994, 372 (6507) :691-694
[6]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[7]  
BIELSCHOWSKY M, 1970, CANCER RES, V30, P834
[8]  
BOUWER HGA, 1994, J IMMUNOL, V152, P5352
[9]  
BOYSE EA, 1970, TRANSPLANTATION, V13, P431
[10]  
BRORSON K, 1989, IMMUNOGENETICS, V20, P273